Recent studies have indicated that innate and adaptive immune systems mediated by natural killer (NK)/cytotoxic T cells are involved in mechanisms of surveillance for tumor elimination. 1, 2 However, ...

Thymoma is a kind of cancer that arises from tissue elements of the thymus and develop in the anterior mediastinum. Thymomas can be associated with a lot of systemic and autoimmune disorders, such as ...

Multiplexed-engineered CAR NK Cell Product Candidate derived from Clonal Master iPSC Line that incorporates Four Functional Elements, including a Novel CAR Targeting the Pan-tumor Associated Stress ...

A team of researchers with the Dana-Farber Cancer Institute and Brigham and Women's Hospital in the U.S. has found that introducing an antibody into a cancerous mouse model prevented the escape of ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

Judy Wang, MD, medical oncologist and clinical trials investigator at Sarah Cannon Research Institute at Florida Cancer Specialists & Research Institute, discussed the mechanism of action and ...

An investigational therapy significantly shrank lung cancer tumors that are notoriously resistant to treatment by encouraging an attack from natural killer (NK) cells in an animal model, a study led ...

Company will initiate Phase 1 study of CLN-619 for relapsed or refractory multiple myeloma, first MICA/B antibody clinical study in hematologic malignancies Follows ongoing clinical study of CLN-619 ...

Modern science has a couple of tricks up its sleeve when it comes to fighting cancer. Nearly a century ago, we discovered that our immune systems can recognize and wipe out these abnormal interlopers.

An experimental therapy AHA-1031 significantly reduced the size of treatment-resistant lung cancer tumors in animal models by stimulating an immune response from natural killer (NK) cells. Published ...

Please provide your email address to receive an email when new articles are posted on . The FDA cleared an investigational new drug application for FT536, a chimeric antigen receptor natural killer ...